In a bold declaration at IIT Roorkee’s international summit, Union Minister Dr. Jitendra Singh revealed that India’s bioeconomy is on track to reach $1 trillion by 2047, securing a spot in the global top three. This projection underscores the transformative potential of biology-led economic models in shaping India’s dominance this century.
The minister emphasized how strategic policy changes and institutional strength are fueling an innovation boom, enabling India to master technologies spanning genetic engineering to quantum computing, and deep-sea exploration to cosmic ventures. ‘The 21st century will be India’s, driven by bioeconomies,’ he asserted.
Key highlights included the National Quantum Mission’s early successes and India’s leadership in pivotal tech sectors worldwide. From $10 billion in 2014, the sector has surged past $165 billion, with 18% yearly growth aiming for $300 billion by 2030. Biotechnology startups have multiplied dramatically from 50 to over 11,000.
Backing this momentum are powerhouse funds: the ₹50,000 crore ANRF and ₹1 lakh crore RDI corpus, tailored for sustained investment in cutting-edge research. Dr. Singh detailed triumphs like Genome India advancements, India’s own CAR-T therapy, mRNA vaccine tech, and the nation’s inaugural indigenous antibiotic.
These developments herald an era of self-reliance and innovation, positioning India not just as a player, but as a leader in the bio-revolution, promising economic vitality and technological sovereignty for generations.
